Rachel C Stanton - FDA Investigator Report

Overview Statistics

12
Total Inspections
10
Total 483s Issued
3
Warning Letters Issued

Inspection Details

Longest Inspection: 47 days
Shortest Inspection: 3 days
Average Length: 10.6 days

Discover the bigger picture. This is just the tip of the iceberg.

Gain access to comprehensive analysis, detailed reports, AI assistant, and much more.

Schedule a Demo

Rachel C Stanton's Recent Inspections

DateCompanyCityCountryFEI Number483
2024-11-08Noble Panacea Labs, Inc.IrvineUnited States3027485555
2024-07-19Orange Lab HoldingsAnaheimUnited States3011893701
2024-05-08Neilmed Pharmaceuticals IncSanta RosaUnited States3002998723
2024-04-05ASC Marketing LtdChula VistaUnited States3015417758
2024-03-01Amphastar Pharmaceuticals, Inc.Rancho CucamongaUnited States3002936358
2023-08-25Central Admixture Pharmacy Services IncSan DiegoUnited States3004378804
2023-06-30Nanoimaging Services, Inc.San DiegoUnited States3013491535
2023-04-19Pacira Pharmaceuticals, Inc.San DiegoUnited States3002783962
2023-03-02Matheson Tri-Gas, Inc.AlbuquerqueUnited States1619650
2023-01-25SOCIETAL CDMO SAN DIEGO, LLCSan DiegoUnited States3003600362

Sign Up to get the complete report.

Download 483s and EIRs for Rachel C Stanton

Rachel C Stanton - Co-Inspectors

Rachel C Stanton's Active Locations

  • United States

Rachel C Stanton's Year-wise Inspection Count

  • 2022:2 inspections
  • 2023:5 inspections
  • 2024:5 inspections
Last Updated: 2025-05-14 06:11:22